Brookline Capital Management Begins Coverage on Envoy Medical (NASDAQ:COCH)

Brookline Capital Management started coverage on shares of Envoy Medical (NASDAQ:COCH) in a report issued on Monday morning, Marketbeat reports. The firm issued a buy rating and a $9.00 target price on the stock. Brookline Capital Management also issued estimates for Envoy Medical’s Q3 2024 earnings at ($0.27) EPS, Q4 2024 earnings at ($0.29) EPS, Q1 2025 earnings at ($0.52) EPS, Q2 2025 earnings at ($0.39) EPS, Q3 2025 earnings at ($0.32) EPS, Q4 2025 earnings at ($0.33) EPS and FY2025 earnings at ($1.56) EPS.

Separately, Ascendiant Capital Markets lifted their price objective on shares of Envoy Medical from $8.50 to $8.75 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd.

Envoy Medical Stock Up 7.9 %

Shares of COCH stock opened at $2.72 on Monday. Envoy Medical has a 52-week low of $0.75 and a 52-week high of $11.46. The firm’s 50-day moving average is $3.00 and its 200-day moving average is $3.17.

Envoy Medical (NASDAQ:COCH) last released its quarterly earnings data on Monday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.03). The business had revenue of $0.07 million during the quarter, compared to analysts’ expectations of $0.08 million. Sell-side analysts forecast that Envoy Medical will post -1.22 earnings per share for the current fiscal year.

Institutional Trading of Envoy Medical

An institutional investor recently bought a new position in Envoy Medical stock. Virtu Financial LLC bought a new stake in Envoy Medical, Inc. (NASDAQ:COCH) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 14,045 shares of the company’s stock, valued at approximately $55,000. Virtu Financial LLC owned approximately 0.07% of Envoy Medical as of its most recent filing with the SEC. Institutional investors and hedge funds own 8.59% of the company’s stock.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.